Brian Markison

Brian Markison is a seasoned executive in the healthcare industry, currently serving as Chief Executive Officer of Lantheus and holding the position of Healthcare Industry Executive at Avista Capital Partners since September 2012. Markison has been a member of the Board of Trustees at The College of New Jersey since 2012 and has held leadership roles on the Board of Directors for multiple companies, including Lead Director and Compensation Committee Chair at Immunomedics and Chairman of the Board & Chief Executive Officer at RVL Pharmaceuticals until February 2024. Additional notable positions include Chairman of the Board of Directors for Lantheus from January 2013 to February 2024, and Chairman and CEO of Osmotica Pharmaceutical Corp. from 2016 to 2021, as well as roles at Fougera Pharmaceuticals and King Pharmaceuticals. Markison holds a Bachelor of Science degree from Iona University.